UP-818-CC Injection in Healthy Chinese Subjects
Clinical trial NCT07355621 · COMPLETED
Trial details
- NCT number
- NCT07355621
- Sponsor
- EnliTISA (Shanghai) Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-14
- Primary completion
- 2023-01-12
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.